A recent drug and alcohol case study offers valuable insights for any safety-critical industry — highlighting trends, gaps, and opportunities that go beyond compliance.
One key takeaway? A mismatch between testing volume and actual risk profile is more common than you think. Too often, testing programs are designed to tick boxes rather than actively mitigate risk. But a “positive picture” — low detection rates, high compliance — can be misleading if it:
Fails to uncover blind spots in your safety strategy
Misrepresents the challenges your workforce actually faces
Masks the very issues that could compromise performance or safety
Effective testing programs should be data-driven, not dictated by tradition, convenience, or budget constraints. They should evolve with your workforce, your risk environment, and your operational realities.
If your current strategy isn’t accurately reviewing risk or highlighting potential threats, it’s time to ask … is your testing program protecting your people — or just your paperwork?
The Office of the National Rail Safety Regulator (ONRSR) offers valuable insights that extend well beyond the rail sector.
ONRSR’s analysis of drug and alcohol testing data from 2018 to 2023 revealed a clear shift – while alcohol detections remain low, drug detections — particularly for Cannabis, Methamphetamine, and MDMA — have doubled.
Despite this, rail operators were still conducting far more alcohol tests than drug tests — 20.5 to 1 — even though drug detections were over 22 times more likely.
This mismatch between testing volume and risk profile is a critical consideration for many organisations. A “positive picture” means little if it fails to uncover where your safety strategy may be falling short.
The rail industry’s experience highlights the importance of aligning drug and alcohol testing programs with actual risk. For example, ONRSR found that infrastructure maintenance staff had the highest rate of positive drug tests — suggesting that role-specific testing strategies can be far more effective than blanket approaches.
Is your workplace testing strategy focused where it matters most? Are you balancing alcohol screening with targeted drug testing to reflect actual risk and improve safety outcomes?
ONRSR is now shifting toward a more strategic, evidence-led Drug and Alcohol testing program. By analysing trends and targeting high-risk roles, they’re improving safety outcomes while supporting industry-led compliance efforts.
This is exactly the kind of approach Alcolizer Technolog supports. Helping clients use Drug and Alcohol specific data to guide testing schedules, refine Drug and Alcohol Policies and Procedures, and ensure resources are directed where they’ll have the greatest impact.
Source
Read the full ONRSR case study here.
SHARE:
Alcolizer Technology Closed 24 Dec to 1 Jan
Onsite Testing continues as normal – your scheduled testing is unaffected.
Skeleton Staff will be available 29 to 31st Dec at our Perth Premises
Ph 1300 789 908 | [email protected]
Normal Operations Resume 2 January 2026
Wishing you a safe & happy holiday!
